Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1995-06-06
1996-12-24
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 942, 424 95, 514184, 514836, 534 16, 544225, 546 11, 436173, A61B 5055
Patent
active
055871445
ABSTRACT:
Heterocyclic chelating agents and salts thereof of formula I: ##STR1## wherein X represents a bond, O or S, or a group CHR.sup.1 or NR.sup.3 ; each R.sup.1 represents H, a group OR.sup.3 or NR.sup.3 R.sup.3, or an alkyl or alkoxyalkyl group optionally substituted by a hydroxyl group or by a group NR.sup.3 R.sup.3 or CON.sup.3 R.sup.3 ;
REFERENCES:
patent: 5348954 (1994-09-01), Almen et al.
patent: 5349668 (1995-08-01), Almen et al.
Fossheim et al., J. Med Chem. 34:819-826 (1991).
Alm en Torsten
Berg Arne
Dugstad Harald
Klaveness Jo
Krautwurst Klaus D.
Hollinden Gary E.
Nycomed Imaging AS
LandOfFree
Diazine chelating agents for diagnostic imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diazine chelating agents for diagnostic imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazine chelating agents for diagnostic imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177012